(CME112) Clinical Hits for 2026: COPD, Sleep, and CHF

Session Summary: Join us for the first session in PALTmed's innauraral Clinical Hits Track. This session will feature discussions of issues relevant to the diagnosis, assessment, and management of heart failure, COPD/asthma, insomnia, and sleep apnea among older adults living in post-acute and long-term care settings. In this session specific updates will focus on expanded use of SGLT-2 and GLP-1 medications for heart failure, new inhaled and biologic therapies for COPD and asthma, upcoming changes in Beer’s classification of medications used to treat insomnia, and advances in the treatment of sleep apnea including implantable devices and oral medications that will be available in the next year. Additionally, we will discuss relevant issues of staffing need and cost of these new treatments compared to prior standards of care as well as identifying opportunities for treatment de-escalation and de-prescribing of potentially inappropriate or harmful medications used to treat these conditions.